Takuya Morita

Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma

Tomohiro Fujiwara, Koji Uotani, Aki Yoshida et al. · Oncotarget · 2017 · 118 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Safety and Pharmacokinetics of Urtoxazumab, a Humanized Monoclonal Antibody, against Shiga-Like Toxin 2 in Healthy Adults and in Pediatric Patients Infected with Shiga-Like Toxin-Producing <i>Escherichia coli</i>

Eduardo López, María M Contrini, Eduardo Glatstein et al. · Antimicrobial Agents and Chemotherapy · 2009 · 103 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +11

Circulating MicroRNA-92b-3p as a Novel Biomarker for Monitoring of Synovial Sarcoma

Koji Uotani, Tomohiro Fujiwara, Aki Yoshida et al. · Scientific Reports · 2017 · 62 citations · Full text

Medicine, Molecular Medicine, Oncology +17

An Epidemiologic Surveillance of Shiga-like Toxin-producing Escherichia coli Infection in Argentinean Children

Eduardo López, María M Contrini, Eduardo Glatstein et al. · The Pediatric Infectious Disease Journal · 2011 · 50 citations

Life Sciences, Infectious Diseases, Pediatrics +17

Clinical and Functional Significance of Intracellular and Extracellular microRNA-25-3p in Osteosarcoma.

Aki Yoshida, Tomohiro Fujiwara, Koji Uotani et al. · PubMed · 2018 · 48 citations · Full text

Medicine, Cancer Biology, Oncology +17